For research use only. Not for human consumption.
Tirzepatide
For topical application only.
Tirzepatide is a synthetic peptide designed for laboratory research. Composed of 39 amino acids, it features a C20 fatty diacid moiety that enhances stability and albumin binding in experimental studies. It is intended strictly for investigations into receptor interactions, signaling pathways, and metabolic research models.
Technical Specifications
| Feature | Details |
|---|---|
| Purity | 99% (Validated by HPLC) |
| Concentration | 10mg per vial |
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight | ~4813.45 g/mol |
| Sequence | Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20-fatty-acid)-Ala-Phe-Val-Gln-Trp-Leu-Met-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ |
| Physical Form | White lyophilized powder |
Key Product Features
- Dual Receptor Research: Targets both GIP and GLP-1 receptors for laboratory studies on receptor binding and signaling.
- COA Verified: Each batch undergoes HPLC and Mass Spectrometry to ensure 99% purity for reproducible research results.
- Enhanced Stability: Lyophilized powder with vacuum-sealed packaging to maintain peptide integrity during storage and handling.
Mechanism of Action (Research Context)
Tirzepatide interacts with GIP and GLP-1 receptors in controlled laboratory environments:
- Receptor Binding Activity: Studied for interaction with GIP and GLP-1 receptors in cell models.
- Signal Pathway Investigation: Used in research exploring receptor-mediated signaling cascades and downstream biochemical responses.
- Comparative Research Applications: Applied in studies comparing dual-receptor activation with single-agonist peptides.
Research FAQ
How should Tirzepatide be stored?
Store the lyophilized powder at 2–8°C for short-term use. For long-term preservation, store at -20°C. Once reconstituted, keep refrigerated and handle under controlled laboratory conditions.
What is the recommended reconstitution procedure?
- Solvent: Bacteriostatic Water or Sterile 0.9% Saline
- Standard Dilution: Add 2mL of solvent for a 10mg vial to achieve a 5mg/mL solution
- Handling: Slowly dispense solvent along the vial wall and gently swirl until fully dissolved. Do not shake to preserve structural integrity.
How does Tirzepatide differ from Semaglutide in research settings?
Tirzepatide is a dual agonist (GLP-1 + GIP), providing a different experimental profile for receptor signaling studies compared with single GLP-1 receptor peptides.
Compliance Notice
For research use only. Not for human consumption.
This product is intended strictly for laboratory research purposes.
For topical application only.
Not for human or animal consumption, injection, or ingestion.
